BiotechTube

AZD3480 + Placebo + Cocktail mix (Caffeine, Bupropion, Rosiglitazone, Omeprazole, Midazolam, Bilirubin)

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Metabolism

Conditions

Metabolism, Alzheimer's Disease

Trial Timeline

Nov 1, 2007 → Sep 1, 2008

NCT ID
NCT00692510

About AZD3480 + Placebo + Cocktail mix (Caffeine, Bupropion, Rosiglitazone, Omeprazole, Midazolam, Bilirubin)

AZD3480 + Placebo + Cocktail mix (Caffeine, Bupropion, Rosiglitazone, Omeprazole, Midazolam, Bilirubin) is a phase 1 stage product being developed by AstraZeneca for Metabolism. The current trial status is completed. This product is registered under clinical trial identifier NCT00692510. Target conditions include Metabolism, Alzheimer's Disease.

What happened to similar drugs?

5 of 20 similar drugs in Metabolism were approved

Approved (5) Terminated (2) Active (15)
✅Xuezhikang Capsule + Atorvastatin Calcium TabletsAstraZenecaApproved
✅cyclosporine micro-emulsionNovartisApproved
✅Fluvastatin sodiumNovartisApproved
🔄liraglutide + placebo + liraglutide + placeboNovo NordiskPhase 3
🔄liraglutide + placeboNovo NordiskPhase 3
🔄Liraglutide 3.0 mg + PlaceboNovo NordiskPhase 3
🔄Semaglutide + Placebo (semaglutide)Novo NordiskPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00692510Phase 1Completed

Competing Products

20 competing products in Metabolism

See all competitors
ProductCompanyStageHype Score
mRNA-3704ModernaPhase 2
0
E2609EisaiPhase 1
29
E2006EisaiPhase 1
29
Xuezhikang Capsule + Atorvastatin Calcium TabletsAstraZenecaApproved
43
Rabeprazole or Esomeprazole or LanzoprazoleAstraZenecaPre-clinical
26
cyclosporine micro-emulsionNovartisApproved
35
Fluvastatin sodiumNovartisApproved
43
NNC0165-1562 + placeboNovo NordiskPhase 1
29
liraglutideNovo NordiskPhase 1
29
NNC9204-0530 + placeboNovo NordiskPhase 1
29
liraglutide + placeboNovo NordiskPhase 1
29
liraglutide + placebo + liraglutide + placeboNovo NordiskPhase 3
40
liraglutide + placeboNovo NordiskPhase 3
40
Liraglutide 3.0 mg + PlaceboNovo NordiskPhase 3
40
Semaglutide + Placebo (semaglutide)Novo NordiskPhase 3
40
liraglutide + orlistat + placeboNovo NordiskPhase 2
35
NNC 0070-0002-0453 + '2-0453 + placeboNovo NordiskPhase 1
21
NNC0194-0499 + PlaceboNovo NordiskPhase 1
29
Semaglutide + PlaceboNovo NordiskPhase 3
40
liraglutide + placeboNovo NordiskPhase 3
40